title: Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
abstract: Seven healthy women were treated with the antiprogesterone RU486, 25 mg/d, on days 1 to 14 of the follicular phase of the menstrual cycle, followed by the synthetic progestin NET in the luteal phase of the cycle. Venous blood samples were collected twice per week. Serum E2, P, and RU486 concentrations were determined by RIAs, and FSH and LH by immunofluorometric assays. Ultrasonography was used to measure the sizes of the follicles. Serum concentrations of FSH and LH were not suppressed during the treatment. Ovulation was apparently suppressed during RU486 treatment according to E2 and P concentrations and ultrasonography findings. During NET treatment, some evidence of ovulation and follicle growth were found during the first treatment periods. During the third treatment cycle, there was no evidence of ovulation (n = 2). Estradiol concentrations were sufficient to stimulate normal proliferative growth of the endometrium during the treatment. Control of bleeding was good. The exact mechanism of action of RU486 on steroid synthesis and ovulation is not clear, but it appears to act at the ovarian level. The evidence indicates that sequential RU486/progestin treatment could be developed to result in suppression of follicular growth and ovulation.
authors.affiliation: University of Helsinki, Finland.
authors.forename: R
authors.initials: R
authors.lastname: Kekkonen
authors.forename: H
authors.initials: H
authors.lastname: Alfthan
authors.forename: M
authors.initials: M
authors.lastname: Haukkamaa
authors.forename: O
authors.initials: O
authors.lastname: Heikinheimo
authors.forename: T
authors.initials: T
authors.lastname: Luukkainen
authors.forename: P
authors.initials: P
authors.lastname: Lähteenmäki
mesh_terms: D000328:Adult; D003276:Contraceptives, Oral; D003279:Contraceptives, Oral, Sequential; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D015735:Mifepristone / Q000494:pharmacology*; D009640:Norethindrone / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects*
chemical_list: D003276:Contraceptives, Oral; D003279:Contraceptives, Oral, Sequential; D015735:Mifepristone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D009640:Norethindrone